Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Exosomes and cell culture-conditioned media improve skin quality and reduce aging signs.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

The placebo microneedle stamp didn't penetrate skin and caused less pain, but blinding was only effective for those with low skin sensitivity.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.